Related Experiment Video
Updated: Jun 12, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Diabetic KK-A(y) mice are highly susceptible to oxidative hepatocellular damage induced by acetaminophen
Kazuyoshi Kon1, Kenichi Ikejima, Kyoko Okumura
1Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan.
Abstract:
Despite pathophysiological similarities to alcoholic liver disease, susceptibility to acetaminophen hepatotoxicity in metabolic syndrome-related nonalcoholic steatohepatitis (NASH) has not been well elucidated. In this study, therefore, we investigated acetaminophen-induced liver injury in KK-A(y) mice, an animal model of metabolic syndrome. Twelve-week-old male KK-A(y) and C57Bl/6 mice were injected intraperitoneally with 300 or 600 mg/kg acetaminophen, and euthanized 6 h later. Liver histology was assessed, and hepatic expression of 4-hydroxy-2-nonenal was detected by immunohistochemistry. Levels of reduced glutathione were determined spectrophotometrically. Phosphorylation of c-Jun NH(2)-terminal kinase (JNK) was analyzed by Western blotting. Hepatocytes were isolated from both strains by collagenase perfusion, and cell death and oxidative stress were measured fluorometrically by use of propidium iodide and 5-(and-6)-chloromethyl-2'7'-dichloro-dihydrofluorescein diacetate acetyl ester, respectively. Acetaminophen induced more severe necrosis and apoptosis of hepatocytes in KK-A(y) mice than in C57Bl/6 mice and significantly increased serum alanine aminotransferase levels in KK-A(y) mice. Acetaminophen-induction of 4-hydroxy-2-nonenal in the liver was potentiated, whereas the levels of reduced glutathione in liver were lower in KK-A(y) mice. Acetaminophen-induced phosphorylation of JNK in the liver was also enhanced in KK-A(y) mice. Exposure to 20 microM tert-butyl hydroperoxide did not kill hepatocytes isolated from C57Bl/6 mice but induced cell death and higher oxidative stress in hepatocytes from KK-A(y) mice. These results demonstrated that acetaminophen toxicity is increased in diabetic KK-A(y) mice mainly due to enhanced oxidative stress in hepatocytes, suggesting that metabolic syndrome-related steatohepatitis is an exacerbating factor for acetaminophen-induced liver injury.
Insights
Metabolic syndrome exacerbates acetaminophen liver injury. Diabetic mice showed increased cell death and oxidative stress, indicating higher susceptibility to acetaminophen toxicity.
Area of Science:
- Hepatology
- Toxicology
- Metabolic Syndrome Research
Background:
- Nonalcoholic steatohepatitis (NASH) shares similarities with alcoholic liver disease.
- Susceptibility to acetaminophen hepatotoxicity in NASH is not well understood.
Purpose of the Study:
- Investigate acetaminophen-induced liver injury in a metabolic syndrome mouse model (KK-A(y) mice).
- Determine if metabolic syndrome exacerbates acetaminophen toxicity.
Main Methods:
- Administered acetaminophen to KK-A(y) and C57Bl/6 mice.
- Assessed liver histology, oxidative stress markers (4-hydroxy-2-nonenal, reduced glutathione), and JNK phosphorylation.
- Evaluated hepatocyte cell death and oxidative stress in vitro.
Main Results:
- KK-A(y) mice exhibited more severe necrosis and apoptosis after acetaminophen exposure.
- Elevated serum alanine aminotransferase levels were observed in KK-A(y) mice.
- Increased oxidative stress and JNK phosphorylation were noted in KK-A(y) mouse livers and hepatocytes.
Conclusions:
- Acetaminophen toxicity is increased in diabetic KK-A(y) mice due to enhanced hepatocyte oxidative stress.
- Metabolic syndrome-related steatohepatitis appears to be an exacerbating factor for acetaminophen-induced liver injury.

